Aurobindo Pharma Profit Rises 33 Percent
Indian drugmaker Aurobindo Pharma reported a 33 percent rise in second-quarter profit on strong US demand and recent acquisitions. Consolidated profit after tax reached 11.26 billion rupees as US formulations revenue increased.
Xurve View
Insights:
Xurve View
AUROBINDO PHARMA LTD posted a 33% increase in second-quarter profit on Wednesday, driven by strong demand in India and international markets. The pharmaceutical firm's consolidated profit after tax rose to 11.26 billion rupees ($118.89 million) in the quarter ended September 30, up from 8.48 billion rupees a year earlier. This earnings jump reflects a broader operational expansion, supported by new product rollouts and strategic acquisitions.
